Press Releases for January 6, 2021
advertisement
- Routine eye scans may give clues to cognitive decline in diabetes
- Provention Bio Announces U.S. FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals
- Company expands recall of diabetes medication due to cancer-causing ingredient